Concepedia
Statistics
Publications
6
Citations
151
H-Index
Active since
2011
Affiliations
Compugen (Israel)(Current)
Sidney Kimmel Comprehensive Cancer Center
Holon Institute of Technology
Weizmann Institute of Science
Meir Azulay is an author at Compugen (Israel) specializing in immunology, tumor immunology, and oncology.
Publications per year
2011–2023
Mouse PVRIG Has CD8+ T Cell–Specific Coinhibitory Functions and Dampens Antitumor Immunity
Benjamin Murter, Xiaoyu Pan, Eran Ophir et al. · Cancer Immunology Research · 2019 · 57 citations · Full text
Life Sciences, Immunology, Oncology +17
Cryoimmunotherapy with local co-administration of ex vivo generated dendritic cells and CpG-ODN immune adjuvant, elicits a specific antitumor immunity
Zoya Alteber, Meir Azulay, Gal Cafri et al. · Cancer Immunology Immunotherapy · 2014 · 32 citations · Full text
Medicine, Immunology, Oncology +17
Split Immunity: Immune Inhibition of Rat Gliomas by Subcutaneous Exposure to Unmodified Live Tumor Cells
Ilan Volovitz, Yotvat Marmor, Meir Azulay et al. · The Journal of Immunology · 2011 · 22 citations
Medicine, Immunology, Oncology +16
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts
Sonja Althammer, Keith E. Steele, Marlon C. Rebelatto et al. · Journal for ImmunoTherapy of Cancer · 2016 · 17 citations · Full text
Characterization of BAY 1905254, an Immune Checkpoint Inhibitor Targeting the Immunoglobulin-Like Domain Containing Receptor 2 (ILDR2)
Julia Huetter, Uwe Gritzan, Ilona Gutcher et al. · Cancer Immunology Research · 2020 · 12 citations
Life Sciences, Cell Biology, Immunology +17
1–5 of 6